UNSPSC 51273603: Articaine or carticaine
Commodity
Code facts
- Part of
-
-
51000000
-
51270000
- 51273600
-
51270000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51273603
Definition
This classification denotes an anesthetic agent with the molecular formula C13H20N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D3SQ406G9X, chemically known as 4-methyl-3-(2-(propylamino)propionamido)-2-thiophenecarboxylic acid, methyl ester but generally known as articaine, which bears US NIH Compound Identifier 32170. Articaine most often comes in base and hydrochloride forms. European Medicines Agency schedules Articaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05577MIG.
Read the full definition
The term ARTICAINE is an International Non-Proprietary Name. World Health Organization schedules articaine in its Anatomical Therapeutic Chemical (ATC) Classification. ARTICAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Articaine or carticaine bears US NLM identifiers UMLS ID C1608295 and NCI Concept Code C72173. SMILES: CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC.CL.
About UNSPSC 51273603
UNSPSC 51273603 Articaine or carticaine is a Commodity code that appears to have little relevant recent activity in state and local procurement. The three most recent opportunities posted under this code—a naloxone and drug deactivation systems procurement from Seminole County, Florida; a therapeutic pharmacy initiative RFI from the Texas Health and Human Services Commission; and a generic multi-source pharmaceuticals RFP from the Minnesota Multistate Cooperative Purchasing Alliance—are unrelated to local anesthetic injectable products. The Seminole County IFB (due July 26, 2023) seeks naloxone and safe drug deactivation systems for community health support, the Texas HHS RFI (due April 3, 2026) explores direct-to-manufacturer prescription fulfillment models outside traditional pharmacy benefit manager arrangements, and the Minnesota MMCAP RFP (due March 26, 2026) solicits generic pharmaceuticals and OTC products through established wholesaler channels across state and local facilities in Minnesota and Oregon. None of these solicitations describe articaine procurement, local anesthetic usage, or dental or medical anesthesia supply chains.
The code's recent activity is driven by state health agencies and cooperative purchasing alliances responding to broader pharmaceutical supply and cost-management priorities rather than by demand for articaine or carticaine specifically. Absence of articaine-specific solicitations in the recent state and local opportunity record suggests that either the code has been assigned incorrectly to these opportunities or articaine procurement is not a current priority across the state and local jurisdictions active in this dataset. Firms evaluating pursuit under this Commodity code should verify whether state and local demand for articaine exists outside the opportunities shown or consider whether the code is actually reflective of their service offering.
Quick answers
What is UNSPSC 51273603?
UNSPSC 51273603 is Articaine or carticaine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51273603?
UNSPSC 51273603 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51273603
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code